Search companies or stocks...
BLTEBelite Bio, Inc
At close · 01 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related…
Current stock price of Belite Bio, Inc (BLTE) stock is $156.70. The stock price is +0.64% higher in the session. The intraday range can be seen from this page. Volume of Belite Bio, Inc (BLTE) stock is 114.06K.
Last updated at 01 Sept 2026, 08:00 pm.
The stock price of Belite Bio, Inc (BLTE) can change with earnings, company news, and overall market sentiment. Belite Bio, Inc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Belite Bio, Inc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BLTE on this page is -83.80. EPS on this page is -1.87. Compare those figures with peers and growth expectations before deciding if the current Belite Bio, Inc price is justified.
Historical performance for Belite Bio, Inc (BLTE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BLTE reacted to past earnings and market events.
Buying Belite Bio, Inc (BLTE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
